Literature DB >> 14188843

RECURRENT CYSTIC FORMATION IN CRANIOPHARYNGIOMA TREATED WITH RADIOACTIVE CHROMIC PHOSPHATE. CASE REPORT.

M C OVERTON, D D SHEFFEL.   

Abstract

Entities:  

Keywords:  ADOLESCENCE; BRAIN DISEASES; CHROMIUM ISOTOPES; CRANIOPHARYNGIOMA; CRANIOTOMY; CYSTS; NEOPLASM RADIOTHERAPY; PHOSPHORUS ISOTOPES; VISION

Mesh:

Substances:

Year:  1963        PMID: 14188843     DOI: 10.3171/jns.1963.20.8.0707

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


× No keyword cloud information.
  6 in total

Review 1.  Management of primary or recurring grossly cystic craniopharyngiomas by means of draining systems. Topic review and 6 case reports.

Authors:  R Spaziante; E De Divitiis; C Irace; P Cappabianca; F Caputi
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

2.  Transethmoidal drainage and arrest of craniopharyngioma by Zenker's solution. (Case report).

Authors:  H H Gass; S Klein
Journal:  Acta Neurochir (Wien)       Date:  1967       Impact factor: 2.216

3.  Morphological, biochemical, ultrastructural, tissue culture and clinical observations of typical and aggressive craniopharyngiomas.

Authors:  T Liszczak; E P Richardson; J P Phillips; S Jacobson; P L Kornblith
Journal:  Acta Neuropathol       Date:  1978-09-15       Impact factor: 17.088

4.  Retreatment of recurrent cystic craniopharyngioma with chromic phosphorus P 32.

Authors:  P P Kumar; R R Good; F M Skultety; E O Jones; W K Chu
Journal:  J Natl Med Assoc       Date:  1986-06       Impact factor: 1.798

5.  The radiotherapy of cystic craniopharyngioma with intracystic installation of 90Y silicate colloid.

Authors:  J Julow; F Lányi; M Hajda; M Simkovics; I Arany; S Tóth; E Pásztor
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

6.  Intracystic irradiation for craniopharyngiomas.

Authors:  Jenő Viktor Julow
Journal:  Pituitary       Date:  2013-03       Impact factor: 4.107

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.